調查批次:CHT2014-07 | 檢體寄出日期:2014-07-21 | 報告回收截止日期:2014-07-28 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
3.09 |
-0.74 |
-19.3 |
-2.4 |
-1.1 |
-80 |
1.15 |
-0.05 |
-4.2 |
-0.5 |
-0.4 |
-17 |
RH07b | RH07 | 3 |
2 |
3 |
4.38 |
0.55 |
14.4 |
1.8 |
0.6 |
59 |
1.12 |
-0.08 |
-6.7 |
-0.8 |
-0.6 |
-27 |
RH14 | RH14 | 7 |
2 |
3 |
4.65 |
0.82 |
21.4 |
2.6 |
0.9 |
88 |
1.18 |
-0.02 |
-1.7 |
-0.2 |
-0.2 |
-7 |
RH15 | RH15 | 7 |
2 |
5 |
3.29 |
-0.54 |
-14.1 |
-1.7 |
-0.8 |
-58 |
1.36 |
0.16 |
13.3 |
1.6 |
1.0 |
53 |
CL009 | CL009 | 4 |
2 |
5 |
2.83 |
-1.00 |
-26.1 |
-3.2 |
-1.4 |
-108 |
1.10 |
-0.10 |
-8.3 |
-1.0 |
-0.7 |
-33 |
CL010 | CL010 | 4 |
2 |
6 |
4.15 |
0.32 |
8.4 |
1.0 |
0.3 |
34 |
0.76 |
-0.44 |
-36.7 |
-4.4 |
-3.0 |
-147 |
CL012 | CL012 | 7 |
2 |
3 |
4.69 |
0.86 |
22.5 |
2.8 |
0.9 |
92 |
1.32 |
0.12 |
10.0 |
1.2 |
0.7 |
40 |
CL013 | CL013 | 7 |
2 |
5 |
3.90 |
0.07 |
1.8 |
0.2 |
-0.1 |
8 |
1.30 |
0.10 |
8.3 |
1.0 |
0.6 |
33 |
CL015 | CL015 | 7 |
2 |
3 |
4.46 |
0.63 |
16.4 |
2.0 |
0.7 |
68 |
1.34 |
0.14 |
11.7 |
1.4 |
0.9 |
47 |
Median of RIA Group |
4.15 |
1.18 |
||||||||||||||
Range of RIA Group |
2.83 - 4.69 |
0.76 - 1.36 |
||||||||||||||
Robust mean of RIA Group |
3.94 ( n = 9 ) |
1.21 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.80 |
0.15 |
||||||||||||||
CV of RIA Group |
20.3% |
12.4% |
||||||||||||||
Median of European RIA Labs |
3.34 ( n = 102 ) |
1.21 ( n = 101 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
3.07 - 3.76 |
1.07 - 1.41 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
4 |
9 |
4.11 |
0.28 |
7.3 |
0.9 |
1.1 |
30 |
1.34 |
0.14 |
11.7 |
1.4 |
1.3 |
47 |
RH02c | RH02 | 7 |
4 |
1 |
2.83 |
-1.00 |
-26.1 |
-3.2 |
-1.7 |
-108 |
0.89 |
-0.31 |
-25.8 |
-3.1 |
-1.2 |
-103 |
RH06 | RH06 | 8 |
4 |
9 |
4.11 |
0.28 |
7.3 |
0.9 |
1.1 |
30 |
1.37 |
0.17 |
14.2 |
1.7 |
1.4 |
57 |
RH07a | RH07 | 1 |
4 |
2 |
3.37 |
-0.46 |
-12.0 |
-1.5 |
-0.5 |
-49 |
1.05 |
-0.15 |
-12.5 |
-1.5 |
-0.3 |
-50 |
RH12 | RH12 | 3 |
4 |
2 |
3.47 |
-0.36 |
-9.4 |
-1.2 |
-0.3 |
-39 |
0.98 |
-0.22 |
-18.3 |
-2.2 |
-0.7 |
-73 |
RH19 | RH19 | 4 |
4 |
2 |
3.73 |
-0.10 |
-2.6 |
-0.3 |
0.2 |
-11 |
1.07 |
-0.13 |
-10.8 |
-1.3 |
-0.2 |
-43 |
RH20 | RH20 | 7 |
4 |
7 |
3.37 |
-0.46 |
-12.0 |
-1.5 |
-0.5 |
-49 |
1.10 |
-0.10 |
-8.3 |
-1.0 |
-0.1 |
-33 |
CL005 | CL005 | 3 |
4 |
9 |
4.15 |
0.32 |
8.4 |
1.0 |
1.2 |
34 |
1.30 |
0.10 |
8.3 |
1.0 |
1.1 |
33 |
CL006a | CL006 | 4 |
4 |
7 |
3.40 |
-0.43 |
-11.2 |
-1.4 |
-0.5 |
-46 |
1.11 |
-0.09 |
-7.5 |
-0.9 |
0.0 |
-30 |
CL008 | CL008 | 7 |
4 |
2 |
3.59 |
-0.24 |
-6.3 |
-0.8 |
-0.1 |
-26 |
1.05 |
-0.15 |
-12.5 |
-1.5 |
-0.3 |
-50 |
CL011 | CL011 | 1 |
4 |
13 |
4.02 |
0.19 |
5.0 |
0.6 |
0.9 |
20 |
1.21 |
0.01 |
0.8 |
0.1 |
0.6 |
3 |
CL014b | CL014 | 7 |
4 |
1 |
3.19 |
-0.64 |
-16.7 |
-2.1 |
-0.9 |
-69 |
0.90 |
-0.30 |
-25.0 |
-3.0 |
-1.2 |
-100 |
Median of CLIA Group |
3.53 |
1.09 |
||||||||||||||
Range of CLIA Group |
2.83 - 4.15 |
0.89 - 1.37 |
||||||||||||||
Robust mean of CLIA Group |
3.62 ( n = 12 ) |
1.11 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.46 |
0.18 |
||||||||||||||
CV of CLIA Group |
12.7% |
16.2% |
||||||||||||||
Median of European CLIA Labs |
3.91 ( n = 979 ) |
1.20 ( n = 1007 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
3.17 - 4.36 |
1.00 - 1.29 |
||||||||||||||
Median of All Labs |
3.73 |
1.12 |
||||||||||||||
Range of All Labs |
2.83 - 4.69 |
0.76 - 1.37 |
||||||||||||||
Robust mean of All Labs |
3.75 ( n = 21 ) |
1.15 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.64 |
0.18 |
||||||||||||||
CV of All Labs |
17.1% |
15.7%
|
||||||||||||||
Median of All European Labs ( Xa ) |
3.83 |
1.20 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
3.13 - 4.35 |
1.00 - 1.31 |
||||||||||||||
Mean of All European Labs |
3.77 ( n = 1149 ) |
1.17 ( n = 1171 ) |
||||||||||||||
SD of All European Labs |
0.58 |
0.16 |
||||||||||||||
CV of All European Labs |
15.4% |
13.5% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.31 |
0.10 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL013, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-07-31